<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url>
<loc>https://kurvetx.com/</loc>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://kurvetx.com/the-solution</loc>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://kurvetx.com/clinical</loc>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://kurvetx.com/our-mission</loc>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://kurvetx.com/our-team</loc>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://kurvetx.com/resources</loc>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://kurvetx.com/contact-us</loc>
<changefreq>monthly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://kurvetx.com/resources/orgenesis-and-kurve-therapeutics-announce-pre-clinical-study-results-for-a-cell-based-oncolytic-virus-bearing-product-demonstrating-over-50-reduction-in-a-murine-glioblastoma-model</loc>
<lastmod>2022-12-22T00:00:00.000Z</lastmod>
<changefreq>yearly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://kurvetx.com/resources/kurve-therapeutics-innovative-medtech-and-specialty-drug-company-focused-on-treating-neurodegenerative-diseases-files-regulation-a-offering</loc>
<lastmod>2022-08-09T00:00:00.000Z</lastmod>
<changefreq>yearly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://kurvetx.com/resources/kurve-therapeutics-announces-next-gen-technology-designed-for-a-new-approach-to-treating-cns-disorders</loc>
<lastmod>2022-06-14T00:00:00.000Z</lastmod>
<changefreq>yearly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://kurvetx.com/resources/transformative-dementia-and-alzheimers-treatment-company-kurve-therapeutics-launches-50m-equity-crowdfunding-raise</loc>
<lastmod>2022-09-14T00:00:00.000Z</lastmod>
<changefreq>yearly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://kurvetx.com/resources/kurve-therapeutics-inc-announces-development-of-new-intellectual-property-to-target-drug-delivery-in-the-brain</loc>
<lastmod>2023-03-21T00:00:00.000Z</lastmod>
<changefreq>yearly</changefreq>
<priority>0.6</priority>
</url>
</urlset>
